Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,698 | -22,106 | -10,348 | -26,754 | -15,072 |
| Depreciation Amortization | 367 | 208 | 166 | 570 | 405 |
| Income taxes - deferred | N/A | N/A | N/A | -164 | N/A |
| Accounts receivable | N/A | N/A | N/A | 12,511 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 764 | N/A |
| Other Working Capital | -18,827 | -6,749 | -5,918 | 21,893 | 19,370 |
| Other Operating Activity | 4,665 | 2,806 | 992 | -9,886 | 3,289 |
| Operating Cash Flow | $-38,493 | $-25,841 | $-15,108 | $-1,066 | $7,992 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,286 | -1,054 | -121 | -1,698 | -1,133 |
| Purchase Of Investment | -48,762 | -26,997 | -8,037 | -117,582 | -67,015 |
| Sale Of Investment | 61,767 | 35,647 | 2,842 | 110,405 | 64,490 |
| Investing Cash Flow | $11,719 | $7,596 | $-5,316 | $-8,875 | $-3,658 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 501 | 280 | N/A | 48,511 | 48,504 |
| Financing Cash Flow | $501 | $280 | $N/A | $48,511 | $48,504 |
| Exchange Rate Effect | -2,526 | -2,001 | -2,349 | -1,581 | -1,234 |
| Beginning Cash Position | 74,867 | 74,867 | 74,867 | 37,878 | 37,878 |
| End Cash Position | 46,068 | 54,901 | 52,094 | 74,867 | 89,482 |
| Net Cash Flow | $-28,799 | $-19,966 | $-22,773 | $36,989 | $51,604 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,493 | -25,841 | -15,108 | -1,066 | 7,992 |
| Capital Expenditure | -1,286 | -1,054 | -121 | -1,698 | -1,133 |
| Free Cash Flow | -39,779 | -26,895 | -15,229 | -2,764 | 6,859 |